AIFF (Firefly Neuroscience) Cash Flow from Others : $1.08 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Firefly Neuroscience Cash Flow from Others?

Firefly Neuroscience's cash flow from others for the three months ended in Dec. 2024 was $1.07 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was $1.08 Mil.

Firefly Neuroscience Cash Flow from Others Historical Data

The historical data trend for Firefly Neuroscience's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firefly Neuroscience Cash Flow from Others Chart

Firefly Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

-0.28

0.43

0.20

Firefly Neuroscience Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Cash Flow from Others	Get a 7-Day Free Trial			1.86	-	-	0.01	1.07

Firefly Neuroscience Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.08 Mil.

Firefly Neuroscience Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Firefly Neuroscience's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Firefly Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Firefly Neuroscience Inc (NAS:AIFF) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 Military Road, Kenmore, NY, USA, 14217

Website

https://fireflyneuro.com

Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.